Response Pharmaceuticals announced it raised $3.9 Million in an initial filing from an offering of $5 Million

Jun 28, 2024•about 1 year ago

Amount Raised

$3.9 Million

Falls ChurchHealthcare

Company Information

Company

Response Pharmaceuticals

Location

1104 WEST BROAD STREET #1064

Falls Church, Virginia, United States

About

Response Pharmaceuticals is developing its lead asset, RDX-002, a first-in-class weight management and cardiometabolic health drug with confirmed efficacy and safety in >550 subjects. All programs are in Phase 2 clinical development.

Response Pharmaceuticals announced it raised $3.9 Million in an initial filing from an offering of $5 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information